Corporate News     04-Feb-23
Natco Pharma's Vizag unit completes USFDA inspection
Natco Pharma announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA) for its Formulation facility in Ramky SEZ, near Visakhapatnam (Vizag), India, which was conducted during the period 30 January 2023 to 3 February 2023.

At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure

Previous News
  Natco Pharma fixes record date for second interim dividend
 ( Market Beat - Reports 12-Aug-24   18:33 )
  Natco Pharma update on legal complaint filed in US
 ( Corporate News - 18-Apr-24   09:30 )
  Natco Pharma consolidated net profit rises 31.18% in the June 2023 quarter
 ( Results - Announcements 09-Aug-23   17:06 )
  Natco Pharma to table results
 ( Corporate News - 27-Jul-24   10:19 )
  Volumes spurt at Natco Pharma Ltd counter
 ( Hot Pursuit - 16-Feb-24   14:30 )
  Natco Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Natco Pharma Ltd down for fifth straight session
 ( Hot Pursuit - 20-Apr-23   13:35 )
  Volumes jump at Vardhman Textiles Ltd counter
 ( Hot Pursuit - 03-Mar-23   14:30 )
  Board of Natco Pharma approves appointment of Chairman
 ( Corporate News - 14-Feb-22   19:09 )
  Natco Pharma Ltd spurts 1.64%, gains for third straight session
 ( Hot Pursuit - 29-May-23   13:05 )
  Natco Pharma Ltd gains for fifth session
 ( Hot Pursuit - 04-Oct-21   13:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top